Drug Multiple Sclerosis

Ponvory

Payments companies reported to CMS as associated with Ponvory. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$977Kassociated payments (2023-2025)
3,045clinicians with associated payments
3companies reporting

By year

2023 $39K
2024 $249K
2025 $689K

Payments reported as associated with Ponvory, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $789K
Family $31K
Psychiatry $14K
Physician Assistant $13K
Gerontology (Nurse Practitioner) $13K
Neurology With Special Qualifications In Child Neurology $12K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ponvory

These are the largest totals companies reported as associated with Ponvory. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mary Ann Picone Teaneck, NJ Neurology (Psychiatry & Neurology) $106,946.73
Daniel Becker Lutherville, MD Neurology (Psychiatry & Neurology) $73,098.88
Daniel Bandari Newport Beach, CA Neurology (Psychiatry & Neurology) $69,486.60
Elliot Frohman Austin, TX Neurology (Psychiatry & Neurology) $49,502.05
Mark Cascione Tampa, FL Neurology (Psychiatry & Neurology) $42,768.25
William Conte Merrillville, IN Neurology (Psychiatry & Neurology) $37,713.92
Sangjin Oh Glen Burnie, MD Neurology (Psychiatry & Neurology) $29,573.21
Mark Janicki Lebanon, IN Neurology (Psychiatry & Neurology) $28,546.37
Allan Perel Staten Island, NY Neurology (Psychiatry & Neurology) $23,113.49
Reuben Valenzuela Peoria, IL Neurology (Psychiatry & Neurology) $21,724.18

Prescribed Ponvory?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.